ERO ERO
Company Profile ↓Company Overview
ERO (ERO) is a publicly traded company listed on with a market capitalization of $3.17B. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Generates a return on equity of 28.2%, reflecting efficient use of shareholder capital.
Return on capital employed stands at 16.1%.
Net profit has compounded at 37.3% per year over the last five years.
Revenue has grown at a 22.6% CAGR over the past five years.
Trades at an undemanding P/E of 12.0.
Maintains a net profit margin of 33.6%.
Recent Developments
- Dec 2025 Revenue of $785.84M (+67.1% YoY); net profit $263.72M.
- Trailing 12 Months Year-on-year growth — revenue +67.1%.
- 5-Year Trend Long-term compounding — revenue CAGR 22.6%, profit CAGR 37.3%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 22.61% |
| 1 Year: | 67.11% |
Compounded Profit Growth
| 5 Years: | 37.33% |
| 1 Year: | - |
Stock Price Performance
| 1 Year: | +120.67% |
| 6 Months: | -17.49% |
| 3 Months: | +17.85% |
| 1 Month: | +22.21% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMAAbove
- Price vs 200-DMAAbove
- Golden Cross1d ago
- RSI (14)66.05 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Strong return on equity of 28.2%.
- Excellent profit margin of 33.6%.
- Compounding revenue at 22.6% over 5 years.
- Profit CAGR of 37.3% over 5 years.
- Generates positive free cash flow.
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
No notable concerns flagged.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Revenue | - | 125.09M | 163.51M | 177.09M | 320.15M | 263.17M |
| Cost of Revenue | - | 69.57M | 96.22M | 119.69M | 155.73M | 157.26M |
| Gross Profit | - | 55.52M | 67.29M | 57.40M | 164.42M | 105.91M |
| Operating Expenses | - | 13.38M | 20.19M | 20.22M | 22.35M | 14.48M |
| Operating Income | - | 42.14M | 47.10M | 37.17M | 142.07M | 91.43M |
| EBITDA | - | 114.55M | 109.96M | 88.04M | 149.48M | 171.56M |
| Interest Expense | - | 563.00K | 631.00K | 7.39M | 6.79M | 6.05M |
| Pretax Income | - | 95.37M | 84.11M | 49.29M | 102.19M | 127.20M |
| Tax Provision | - | 14.74M | 13.08M | 12.77M | 23.45M | 17.89M |
| Net Income | - | 80.23M | 70.55M | 35.98M | 76.97M | 108.77M |
| Diluted EPS | - | 0.77 | 0.68 | 0.35 | - | 1.04 |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Revenue | - | 426.39M | 427.48M | 470.26M | 785.84M |
| Cost of Revenue | - | 239.22M | 270.63M | 289.71M | 441.21M |
| Gross Profit | - | 187.18M | 156.84M | 180.55M | 344.63M |
| Operating Expenses | - | 59.58M | 64.35M | 61.92M | 77.55M |
| Operating Income | - | 127.59M | 92.50M | 118.63M | 267.08M |
| EBITDA | - | 206.48M | 208.15M | 13.78M | 462.03M |
| Interest Expense | - | 21.13M | 12.78M | 1.81M | 15.37M |
| Pretax Income | - | 126.38M | 112.35M | -75.44M | 330.96M |
| Tax Provision | - | 23.32M | 18.05M | -7.65M | 64.05M |
| Net Income | - | 101.83M | 92.80M | -68.47M | 263.72M |
| Diluted EPS | - | 1.10 | 0.98 | -0.66 | 2.53 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Total Assets | - | 1.19B | 1.51B | 1.46B | 1.92B |
| Current Assets | - | 392.43M | 199.49M | 141.79M | 276.21M |
| Cash & Equivalents | - | 177.70M | 111.74M | 50.40M | 105.44M |
| Inventory | - | 30.95M | 42.25M | 42.09M | 107.11M |
| Receivables | - | 10.29M | 5.71M | 18.40M | 41.06M |
| Total Liabilities | - | 645.91M | 702.36M | 866.95M | 986.02M |
| Current Liabilities | - | 129.12M | 173.80M | 211.71M | 260.72M |
| Long Term Debt | - | 402.35M | 405.85M | 556.30M | 551.40M |
| Total Debt | - | 429.02M | 445.84M | 620.07M | 632.35M |
| Total Equity | - | 538.59M | 804.25M | 587.13M | 935.53M |
| Shares Outstanding | - | 92.18M | 102.75M | 103.56M | 104.19M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | 143.39M | 163.10M | 145.42M | 395.14M |
| Investing Cash Flow | - | -425.81M | -308.17M | -335.38M | -278.59M |
| Financing Cash Flow | - | 327.30M | 77.75M | 131.16M | -59.73M |
| Capital Expenditure | - | -295.82M | -460.65M | -337.59M | -282.44M |
| Free Cash Flow | - | -152.43M | -297.55M | -192.17M | 112.70M |
| Net Change in Cash | - | 44.88M | -67.32M | -58.81M | 56.82M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Gross Margin % | - | 43.9% | 36.7% | 38.4% | 43.9% |
| Operating Margin % | - | 29.9% | 21.6% | 25.2% | 34.0% |
| Net Margin % | - | 23.9% | 21.7% | -14.6% | 33.6% |
| ROE % | - | 18.9% | 11.5% | -11.7% | 28.2% |
| ROCE % | - | 12.0% | 6.9% | 9.5% | 16.1% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for ERO
Ero Copper Reports Second Quarter 2026 Operating and Financial Results
(all amounts in US dollars, unless otherwise noted) VANCOUVER, British Columbia, Aug. 05, 2026 (GLOBE NEWSWIRE) -- Ero Copper Corp. (TSX: ERO, NYSE: ERO) (“Ero” or the “Company”) is pleased to announce its operating and financial results fo…
5 Non-Ferrous Metal Mining Stocks to Watch in a Challenging Industry
Despite the Zacks Mining - Non Ferrous industry's weak near-term outlook, stocks like SCCO, FCX, LUNMF, UUUU and ERO are worth keeping an eye on given their growth potential.
Ero Copper (TSX:ERO) Could Be 23% Undervalued On Its Production Ramp Up Story
Ero Copper (TSX:ERO) has drawn attention after its recent share performance, with the stock down about 6% year to date but up roughly 96% over the past year. Investors are reassessing what now drives the story. See our latest analysis for E…
Coeur Mining Set to Report Q2 Earnings: Here's What to Expect
CDE is slated to report Q2 2026 results on Aug. 5, with earnings expected to rise 10% year over year as investors watch costs and mine performance.
Wall Street Analysts See a 37.89% Upside in Ero Copper (ERO): Can the Stock Really Move This High?
The consensus price target hints at a 37.9% upside potential for Ero Copper (ERO). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock wi…
Zacks.com featured highlights include Cenovus Energy, Five9, PagSeguro, Ero Copper and Par Pacific
CVE, FIVN, PAGS, ERO and PARR screen well on EV-to-EBITDA, highlighting five bargain stocks with solid earnings growth potential.
ERO — Frequently Asked Questions
What is the current share price of ERO?
As of 2026-08-05 17:25 PDT, ERO trades at $30.43 on NASDAQ/NYSE. Its 52-week range is $13.55 to $38.03.
What is the market capitalisation of ERO?
ERO has a market capitalisation of $3.17B on NASDAQ/NYSE.
What is the P/E ratio of ERO?
ERO trades at a trailing price-to-earnings (P/E) ratio of 12.03. Its price-to-book (P/B) ratio is 3.39.
What is the return on equity (ROE) of ERO?
ERO has a return on equity (ROE) of 28.19%. Its return on capital employed (ROCE) is 16.06%.
Is ERO a good stock to buy?
This page provides a data-driven analysis of ERO, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.